From Precision to Execution: How Sponsors Are Re‑Engineering Value Creation at Speed
Insights from the 2026 Healthcare Private Equity Conference (HPE)
As healthcare private equity (PE) activity ramps up, returns are increasingly driven by organic growth and EBITDA improvement through efficiency. In this environment, there is less room for execution missteps once assets enter a portfolio. In 2025, global healthcare PE recorded more than $191 billion in disclosed deal value across 445 buyouts (Bain, Global Healthcare Private Equity Report, 2026), with continued momentum expected across biopharma and healthcare services in 2026, particularly in healthtech and healthcare IT (PitchBook, 2026 Healthcare Outlook, 2026).
These conditions formed the backdrop for discussions at HPE. Unpacking from Miami meant more than shaking the sand out of suitcases; conversations reflected a shift from caution to action as deal activity ramps across the sector.
What stood out at HPE was how sponsors are responding to changing dynamics. Building on themes WittKieffer established in The Long Hold: Fortifying Leadership in Private‑Equity‑Backed Healthcare, sponsors are re-centering on fundamentals in value creation. Add-ons funded by low-cost money and benefiting from multiple arbitrage will continue to be part of the playbook, but no longer the main engine of returns. In other words, the primary mechanisms of value creation are reverting to organic growth and operating excellence to produce sustainable profit growth. Critically, these levers must be mobilized from ownership inception to optimize the timing, probability, and magnitude of value creation.
Growth Leadership is Being Deployed Earlier
Sponsors are re‑engaging growth across healthcare portfolios under tighter assumptions than in prior cycles. Returns now hinge on organic lift, but it is no longer expected to compensate for weak execution or operating gaps. One signal surfaced repeatedly at HPE: the resurgence of Chief Growth Officer and Chief Revenue Officer mandates across healthcare portfolios. Sponsors described deploying growth leadership earlier in the hold period, not as a late‑stage accelerator, but as an operating lever to institutionalize growth through operating discipline, systems, and accountability.
Execution Breaks First at the Operating Layer
At HPE, sponsors were direct about where value creation most often breaks down: not in strategy, but at the operating layer. Sponsors described situations in which the investment thesis is sound and market fundamentals hold, yet performance diverges across assets and sites within the same platform. The differentiator is operating consistency.
Risk accumulates where strategy meets day‑to‑day decision‑making. When sponsor expectations are not translated cleanly into operating priorities, momentum erodes early, even when the value‑creation plan itself is clear. With tighter timelines and less margin for error, operating variability is no longer tolerated.
AI surfaced in this context as a concentrated operating‑layer risk rather than a standalone growth lever. Sponsors described scrutinizing data infrastructure, governance, and workflow integration early in diligence. Where execution discipline, ownership, or operating readiness are unclear, projected upside is removed from the value‑creation plan rather than deferred.
Flexible Leadership Deployment as an Execution Lever
Sponsors are no longer treating leadership deployment as a linear, post‑close sequence that can wait for traditional hiring timelines. When operating complexity and integration pressures outpace the team in place, they are deploying interim and on‑demand leadership as extensions to operating capability and capacity.
At HPE, this surfaced most clearly in how sponsors are front‑loading integration and operational support across multi‑site platforms.
Flexible leadership is being used to close timing gaps between deal delivery and operating reality. Sponsors are deploying capacity where implementation risk concentrates, protecting momentum in the first phase of ownership while longer‑term leadership decisions are made.
Board Composition Is Being Re‑Tooled Under Operating Pressure
At HPE, sponsors were explicit about how operating pressure is reshaping governance in certain situations. Where operating complexity and integration demands leave little margin for delay, boards composed primarily of financial sponsors can constrain execution rather than support it. Sponsors described adding independent directors with hands‑on operating experience to complement financial oversight and support management teams in value‑creation plan execution. These operator‑directors are selected for their ability to engage directly with leadership on growth delivery and operational scaling. In this cycle, boards are being shaped to function under pressure. Sponsors are adjusting governance structures to clarify priorities, challenge assumptions in real time, and reduce friction at key inflection points.
What emerged from HPE was not a new theory of value creation. It was evidence of a fundamental shift in how sponsors are managing execution risk in real time. Leadership deployment is no longer a post-close sequence; it is an operating lever deployed at the speed of capital redeployment. Ultimately, the winners will not be those with the best strategy on paper. They will be the ones who can execute it at pace, with the right operators in place, from day one.
